Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

18 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Colestid Articles

IMPAX' generic Colestid OKed in USA

8 May 2006

First Launch Of Parke-Davis' Lipitor

10 February 1997

Two More Launches For Upjohn's Freedox

24 April 1995

COLESTID TO BE LAUNCHED BY DECEMBER

8 August 1994

UPJOHN OUTLINES STRATEGIC DIRECTIONS

18 April 1994

JAPAN PHARMA MARKET IS LARGE, POOR PERFORMER

14 March 1994

UPJOHN LAUNCH

7 September 1992

UPJOHN UPDATES ON R&D PROGRESS

13 April 1992

HYPOLIPIDEMICS INFO

23 March 1992

Showing 1-9 of 9 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Elan puts up formal "for sale" notice
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Elan puts up formal "for sale" notice
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS